Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.60
0.00 (0.00%)
At close: Jun 2, 2026, 4:00 PM EDT
10.61
+0.01 (0.09%)
After-hours: Jun 2, 2026, 4:00 PM EDT

DMAA Statistics

Total Valuation

DMAA has a market cap or net worth of $357.40 million. The enterprise value is $357.49 million.

Market Cap357.40M
Enterprise Value 357.49M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

DMAA has 33.72 million shares outstanding.

Current Share Class 33.72M
Shares Outstanding 33.72M
Shares Change (YoY) n/a
Shares Change (QoQ) -28.99%
Owned by Insiders (%) 1.19%
Owned by Institutions (%) 69.75%
Float 29.13M

Valuation Ratios

The trailing PE ratio is 38.66.

PE Ratio 38.66
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings 53.70
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -1.09%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +4.64% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +4.64%
50-Day Moving Average 10.55
200-Day Moving Average 10.39
Relative Strength Index (RSI) 58.41
Average Volume (20 Days) 42,623

Short Selling Information

The latest short interest is 96,507, so 0.29% of the outstanding shares have been sold short.

Short Interest 96,507
Short Previous Month 103,808
Short % of Shares Out 0.29%
Short % of Float 0.33%
Short Ratio (days to cover) 0.42

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -2.63M
Pretax Income 6.66M
Net Income 6.66M
EBITDA n/a
EBIT -2.63M
Earnings Per Share (EPS) $0.27

Balance Sheet

The company has $14,887 in cash and $100,000 in debt, with a net cash position of -$85,113 or -$0.00 per share.

Cash & Cash Equivalents 14,887
Total Debt 100,000
Net Cash -85,113
Net Cash Per Share -$0.00
Equity (Book Value) -7.38M
Book Value Per Share -0.30
Working Capital -477,282

Cash Flow

Operating Cash Flow -379,193
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing 100,000
Free Cash Flow n/a
FCF Per Share n/a

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DMAA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 1.86%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1